Bowel-cleansing drugs to get black-box warning in U.S.

12/11/2008 | Washington Post (tiered subscription model), The

The FDA ordered a black-box warning for Salix Pharmaceuticals' Visicol and OsmoPrep to alert consumers about the risk of kidney injury from the oral sodium phosphate drugs. The warning is intended for patients older than 55, people who are dehydrated or have kidney disorders and individuals who use medicines that affect kidney function.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN